Netherlands - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Netherlands Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 11.4% year on year. At 12 Cases in 2019, the country was number 244 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 12.00
2018 12.00
2017 11.00
2016 15.00
2015 12.00
Download all data from 2005 to 2019

How does Netherlands rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
239 #239
Guyana
15 2019 +7.1 % +30.3 % View data
244 #244
Netherlands
12 2019 +0.0 % +11.4 % View data
244 #244
Suriname
12 2019 -7.7 % +5.9 % View data
Compare all 359 countries

Go Top